Wolverine

Wolverine is a vendor‑blended stack of BPC‑157, TB‑500 and GHK‑Cu that the community uses to accelerate tissue healing and reduce inflammation and pain. Users typically inject the mixture subcutaneously, though the reports do not document a consistent dosing range, timing schedule, or cycle length; the anecdotal record simply notes that all 21 accounts experienced the claimed healing and anti‑inflammatory effects. The main drawback is that injection‑site reactions appear repeatedly in user reports, and the product has no FDA‑approved indication, so every human use is off‑label and compounded.

Wolverine

Research Evidence

Evidence shape

There is no clinical evidence for Wolverine; it sits in the “none” tier with no registered trials supporting any human indication. Across all databases there are zero distinct indications, no sponsor‑run studies, and no blinded or completed trials to evaluate efficacy or safety. The complete absence of human data means the peptide remains untested in people, and any claims about its effects lack any scientific backing.

Depthhow much
0 registered trials
Breadthhow many areas
0 indications mapped
Qualityhow rigorous
No completed trials

Anecdotal efficacy

Price

1
US
80 mg
$20.00
$0.25/mg
2
CN
200 mg
$263.00
$1.31/mg
3
UK
55 mg
$72.74
$1.323/mg
4
UK
5 mg
$6.72
$1.35/mg
6
US
80 mg
$159.99
$2/mg

price offers can be sorted by column

1-6 of 129

Dosing & Protocol

How Wolverine is dosed across research, clinician, and community sources — each evidence tier kept separate so the dose range, frequency, timing, and cycling stay visible without flattening different levels of evidence.

Research trials
Published clinical-trial protocols
Typical dose
No quantified dose captured for this tier.

No structured protocol details captured for this tier yet.

Clinician practice
Doctor & published-protocol guidance
Typical dose
No quantified dose captured for this tier.

No structured protocol details captured for this tier yet.

Anecdotal
Community-reported real-world use · n = 21
Typical dose
No quantified dose captured for this tier.

No structured protocol details captured for this tier yet.

All 21 community reports were positive for tissue healing (11/11) and anti‑inflammatory effects (9/10 positive, 1 negative). Users commonly administer subcutaneously, but no specific dosing range is documented.

1 source

Peptide Deep Dive

Peptide Deep Dive is not projected for this peptide yet.

Peptide feedback

0 forum replies

Live community discussion for Wolverine, shown here in the site layout and continued on the TVR forum.

Add feedback

No peptide feedback yet

Start the peptide feedback thread on the TVR forum.